Table 1.
SIRT | Cell Location | Tissue Expression | Enzyme Activity | Major Functions | Implication in AD Pathophysiology and/or Therapy (In Vitro/In Vivo Animal Model for AD) |
---|---|---|---|---|---|
SIRT1 | Nuclear Cytosolic |
Brain, retina, musculo-skeletal tissue, adipose tissue, heart, liver kidney, testis, uterus, blood vessels | Deacetylase, deacylase | DNA repair, Chromatin regulation, Cell cycle, Cell, survival, Neuroprotection, Metabolism, Cardio-vascular protection, Inflammation Ageing. |
SIRT1 is involved in the regulation of APP processing and the clearance of Aβ and its activation provides neuroprotection [90]. SIRT1 modulates tau phosphorylation by deacetylating tau protein and influencing the activity of kinases and phosphatases, such as PP2A activation leading to a decrease in tau phosphorylation [91]. SIRT1 regulates neuroinflammation via NF-κB [52,92], highly expressed in AD. SIRT1 promotes mitochondrial biogenesis via activation of mitochondrial PGC-1α gene expression [93], which may lead to a reduction in oxidative stress reported in AD. |
SIRT2 | Nuclear Cytosolic | Brain, musculo-skeletal tissue, adipose tissue, heart, liver kidney, blood vessels | Deacetylase, deacylase | Cell control, Neuroinflammation, Myelination, Oxidation, Metabolism. |
Activation of SIRT2 promotes tau phosphorylation via ERK activation. SIRT2 inhibition leads to reduced tau pathology and an increase in Aβ clearance in AD [94,95,96]. |
SIRT3 | Mitochondrial Nuclear Cytosolic |
Brain, musculo-skeletal tissue, adipose tissue (particularly brown), heart, liver kidney, oocytes blood vessels | Deacetylase, Decrotonylase |
Cell, survival, Neuroprotection, Metabolism, Mitochondrial homeostasis, Inflammation, Oxidation (including FA), Thermogenesis, Ageing. |
SIRT3 activation promotes the increase in neuronal survival and decrease apoptotic gene expression, reduces oxidative stress, regulates mitochondrial homeostasis (including increased bioenergetics), decreases neuroinflammation present in AD [97,98,99] |
SIRT4 | Mitochondrial | Brain, heart, kidney, liver, blood vessels, pancreatic β-cells | Deacetylase, ADP-ribosyltransferase, Lipoamidase, Deacylase | DNA repair, cell survival, Neurodegeneration, Cardio-vascular protection, Oxidation, Metabolism. |
SIRT4 activation decrease oxidative stress and increase energy production in mitochondria [81]. SIRT4 modulates apoptosis via the mTOR pathway in AD [100]. |
SIRT5 | Mitochondrial Nuclear Cytosolic |
Brain, heart, kidney, liver, blood vessels, testis, thymus, musculoskeletal tissue | Deacetylase, Desuccinylase, Demalonylase, Deglutarylase | Oxidation (including FA) |
SIRT5 regulates mitochondrial enzymes (via post-translational modifications), energy metabolism and response to oxidative sterss (via SOD2) [101]. Activation of SIRT5 represses Aβ production in AD by targeting autophagy [102] |
SIRT6 | Nuclear Cytosolic |
Brain, retina, heart, kidney, liver, blood vessels, musculoskeletal tissue, thymus, testis, ovary | Deacetylase, Demyristoylase, ADP-ribosyl-transferase, Deacylase | DNA repair, Metabolism, Cardio-vascular protection, Inflammation Ageing. |
Activation of SIRT6 is provides DNA stability and promotes DNA repair, leading to neuronal protection in AD [103]. Activation of SIRT6 reduces tau phosphorylation by deacetylating of tau protein [104]. |
SIRT7 | Nucleolar Nuclear |
Brain, heart, kidney, liver, blood cells, musculoskeletal tissue, spleen, testis | Deacetylase, Desuccinylase | Metabolism, Thermogenesis, Ageing. |
SIRT7 deficiency protects against Aβ-induced apoptosis via regulation of ROS in cells [105]. |